Communiqués RenovoRx, Inc.

Actions

RNXT

US75989R1077

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
1,27 ^USD	+1,60 %		+9,48 %	-44,54 %

26/06	Le centre médical de l'Université du Nebraska lance le recrutement de patients pour l'essai clinique pivot de phase III TIGeR-PaC de RenovoRx	CI
10/06	RenovoRx, Inc. nomme Ryan Witt au poste de premier vice-président, responsable de la stratégie d'entreprise et des partenariats	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®	08/07	AQ
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial	26/06	AQ
RenovoRx : Trans Arterial Micro Perfusion For Improved Drug Delivery	19/06	PU
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships	10/06	AQ
RenovoRx CEO Issues Update Letter to Shareholders	30/05	BU
Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery	21/05	BU
RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024	14/05	BU
RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024	02/05	BU
RenovoRx Regains Compliance with Nasdaq Stockholders Equity Requirement	19/04	AQ
RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement	18/04	BU
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech	16/04	AQ
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting	16/04	BU
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026	15/04	BU
RenovoRx Announces $11.1 Million at Market Private Placement	08/04	BU
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024	08/04	AQ
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024	05/04	BU
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024	12/03	BU
RenovoRx Highlights Key Leadership Promotions	11/03	AQ
RenovoRx Highlights Key Leadership Promotions	08/03	BU
RenovoRx CEO Issues Letter to Shareholders	06/02	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués RenovoRx, Inc.

Actions

RNXT

US75989R1077

Communiqués

Filtres